..Many studies have proven relevant reduction of fatal pulmonary embolism due to improved medical practice aimed to provide proper thromboembolic prophylactic therapy.
RESULTS: Despite scientific efforts in clinical prevention, influence of some patients demographic variables are often underestimated (i.e. older age..) and real burden of absolute venous thromboembolic risk and thromboprophylactic efficacy remain unclear.
Moreover, establishment and development of Emergency and Acute Care Departments select a patients population that shows more complex features and comorbidities when compared to classical Medicine wards patients, thus making harder the exact choice regarding when and how to administer thromboembolic prophylactic therapy.
CONCLUSION: The simultaneous assessment of the thrombotic and haemorrhagic risk is the key for an adequate safe prophylaxis, a higher appropriateness of antithrombotic prophylaxis. Thus it is routinely recommended to use proper tools of VTE risk evaluation in order to set the best risk/ benefit therapeutic strategy in medically ill patients
Full article here